MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
attributable to arrowhead...
-$132,732K
(-135.83%↓ Y/Y)
Net loss
attributable to...
-$4,840K
(-87.45%↓ Y/Y)
Net (gain) income
including noncontrolling...
-$137,572K
(-137.40%↓ Y/Y)
Gain on vie's sale of
ipr&d assets
$19,000K
Interest income
$16,869K
(75.44%↑ Y/Y)
(gain) income before
income tax expense and...
-$137,565K
(-137.22%↓ Y/Y)
Income tax expense
$7K
(-99.60%↓ Y/Y)
Total other income
(expense)
$3,695K
(131.89%↑ Y/Y)
Interest expense
$23,846K
(10.20%↑ Y/Y)
Loss on equity method
investment
-$6,719K
Other, net
-$1,609K
(-467.35%↓ Y/Y)
Operating (gain) income
-$141,260K
(-137.06%↓ Y/Y)
Revenue
$73,737K
(-86.41%↓ Y/Y)
Total operating
expenses
$214,997K
(33.12%↑ Y/Y)
Research and development
$173,253K
(30.17%↑ Y/Y)
Selling, general and
administrative
$41,744K
Back
Back
Income Statement
source: myfinsight.com
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)